Posts

Cyclin-Dependent Kinase Orchestrates Mitosis Timing

In the intricate symphony of cell division, timing and localization of molecular...

IFNγ-Activated Dendritic Cells Defend Brain Metastasis

In a groundbreaking new study slated to reshape our understanding of central ner...

Barcoded Tracing Reveals Astrocyte-Glioma Suppression

In the relentless battle against glioblastoma (GBM), one of the deadliest primar...

Choice Dynamics and Geometry in Premotor Cortex

In a groundbreaking study published in Nature, researchers from multiple institu...

Oxford Scientists Unveil Breakthrough Method to Capture...

In a groundbreaking advancement poised to transform the landscape of ultra-inten...

Unraveling Cytarabine’s Neurotoxic Mechanism

In the intricate landscape of neuronal biology, the epigenetic modifications of ...

In-line NMR Drives Orthogonal Real-Plastics Transformation

The mounting crisis of plastic waste has escalated into a grave environmental ch...

Daily Electric Field Therapy Boosts Spinal Injury Recovery

In a groundbreaking study poised to reshape the therapeutic landscape for spinal...

FDA approves AstraZeneca and Daiichi Sankyo’s Datroway ...

The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deru...

FDA genAI reviews hinge on clarity of dossiers

The FDA's new genAI-assisted scientific review technology, named Elsa, was offic...

Zambon gains Chinese regulatory authority approval for ...

Zambon Pharma has received approval from Chinese regulatory authorities and laun...

Navamedic signs agreement to acquire dne pharma

Navamedic has signed an agreement for the acquisition of Norwegian company dne p...

Hims & Hers shares plummet 35% as Novo Nordisk pulls pa...

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after l...

Alzheimer’s R&D resurgence driven by $16.8bn in acquisi...

Acquisitions involving innovator drugs have grown year-on-year with total deal v...

Revolution Medicines partners Royalty Pharma on $2bn fu...

Revolution Medicines has partnered Royalty Pharma for $2bn to support developmen...